Overview

Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This trial seeks to confirm the response rate for estrace treatment in a patients with hormone receptor positive metastatic breast cancer heavily pre-treated with modern endocrine therapies.
Phase:
Phase 2
Details
Lead Sponsor:
Georgetown University
Treatments:
Anastrozole
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Polyestradiol phosphate